29th Nov 2007 07:01
Skyepharma PLC29 November 2007 SkyePharma PLC BOARD CHANGE LONDON, UK, 29 November 2007-- SkyePharma PLC (LSE: SKP) announces today that DrDavid Ebsworth has resigned as a Non-Executive Director of the Company, witheffect from the close of business on 28 November 2007, in order to concentrateon his other commitments. He will be replaced as Chairman of the RemunerationCommittee by Dr Jerry Karabelas. Jeremy Scudamore, Non-Executive Chairman, said: "The Board is very grateful toDavid for his hard work, advice and commitment over the past five years. Wewish him all the best for the future." For further information please contact: SkyePharma PLC Frank Condella +44 20 7491 1777 Ken Cunningham Peter Grant Financial Dynamics (UK Enquiries) David Yates +44 20 7831 3113 Deborah Scott Trout Group (US Enquiries) Christine Labaree +1 617 583 1308 Seth Lewis About SkyePharma PLC Using its proprietary drug delivery technologies, SkyePharma develops newformulations of known molecules to provide a clinical advantage and life-cycleextension. The Company has eleven approved products in the areas of oral,inhalation and topical delivery. The Group's products are marketed throughoutthe world by leading pharmaceutical companies. For more information, visitwww.skyepharma.com This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SKP.L